Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families - PubMed (original) (raw)
doi: 10.1007/s001250050666.
H Blanché, M Vaxillaire, C Bellanné-Chantelot, V C Pardini, J Timsit, P Passa, I Deschamps, J J Robert, I T Weber, D Marotta, S J Pilkis, G M Lipkind, G I Bell, P Froguel
Affiliations
- PMID: 9049484
- DOI: 10.1007/s001250050666
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families
G Velho et al. Diabetologia. 1997 Feb.
Abstract
Mutations in glucokinase are associated with defects in insulin secretion and hepatic glycogen synthesis resulting in mild chronic hyperglycaemia, impaired glucose tolerance or diabetes mellitus. We screened members of 35 families with features of maturity-onset diabetes of the young for mutations in the glucokinase gene and found 16 different mutations. They included 14 new mutations in the glucokinase gene: 9 missense mutations (A53S, G80A, H137R, T168P, M210T, C213R, V226M, S336L and V367M); 2 nonsense mutations (E248X and S360X); a deletion of one nucleotide resulting in a frameshift (V401del1); a substitution of a conserved nucleotide at a splice acceptor site (L122-1G-->T); and a 10 base pair deletion that removed the GT of the splice donor site and the following eight nucleotides (K161 + 2del10). In addition, we found two previously identified mutations: R186X and G261R. Study of 260 subjects with glucokinase-deficient hyperglycaemia from 42 families with 36 different GCK mutations made it possible to define the clinical profile of this subtype of non-insulin-dependent diabetes mellitus (NIDDM). Hyperglycaemia due to glucokinase deficiency is often mild (fewer than 50% of subjects have overt diabetes) and is evident during the early years of life. Despite the long duration of hyperglycaemia, glucokinase-deficient subjects have a low prevalence of micro- and macro-vascular complications of diabetes. Obesity, arterial hypertension and dyslipidaemia are also uncommon in this form of NIDDM.
Similar articles
- Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, et al. Froguel P, et al. N Engl J Med. 1993 Mar 11;328(10):697-702. doi: 10.1056/NEJM199303113281005. N Engl J Med. 1993. PMID: 8433729 - Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young.
Mantovani V, Salardi S, Cerreta V, Bastia D, Cenci M, Ragni L, Zucchini S, Parente R, Cicognani A. Mantovani V, et al. Hum Mutat. 2003 Oct;22(4):338. doi: 10.1002/humu.9179. Hum Mutat. 2003. PMID: 12955723 - Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus.
Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P, et al. Vionnet N, et al. Nature. 1992 Apr 23;356(6371):721-2. doi: 10.1038/356721a0. Nature. 1992. PMID: 1570017 - Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
Hattersley AT. Hattersley AT. Diabet Med. 1998 Jan;15(1):15-24. doi: 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M. Diabet Med. 1998. PMID: 9472859 Review.
Cited by
- The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing.
GoodSmith MS, Skandari MR, Huang ES, Naylor RN. GoodSmith MS, et al. Diabetes Care. 2019 Dec;42(12):2247-2255. doi: 10.2337/dc19-0486. Epub 2019 Sep 26. Diabetes Care. 2019. PMID: 31558549 Free PMC article. - Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness.
Pruhova S, Dusatkova P, Kraml PJ, Kulich M, Prochazkova Z, Broz J, Zikmund J, Cinek O, Andel M, Pedersen O, Hansen T, Lebl J. Pruhova S, et al. Int J Endocrinol. 2013;2013:718254. doi: 10.1155/2013/718254. Epub 2013 Sep 11. Int J Endocrinol. 2013. PMID: 24101925 Free PMC article. - Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice.
Wang R, Gao H, Xu W, Li H, Mao Y, Wang Y, Guo T, Wang X, Song R, Li Z, Irwin DM, Niu G, Tan H. Wang R, et al. Gene. 2013 Mar 10;516(2):248-54. doi: 10.1016/j.gene.2012.12.036. Epub 2013 Jan 2. Gene. 2013. PMID: 23291412 Free PMC article. - Visualising insulin secretion. The Minkowski Lecture 2004.
Rutter GA. Rutter GA. Diabetologia. 2004 Nov;47(11):1861-72. doi: 10.1007/s00125-004-1541-1. Epub 2004 Nov 17. Diabetologia. 2004. PMID: 15551048 - Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes.
Schiabor Barrett KM, Telis N, McEwen LM, Burrows EK, Khuder B, Judge DP, Pawloski PA, Grzymski JJ, Washington NL, Bolze A, Cirulli ET. Schiabor Barrett KM, et al. Commun Med (Lond). 2024 Nov 20;4(1):239. doi: 10.1038/s43856-024-00663-z. Commun Med (Lond). 2024. PMID: 39567669 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous